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Abstract
Heyde's syndrome (HS) is described as the association between recurrent bleeding from angiodysplasia of the
gastrointestinal tract and aortic stenosis. Aortic valve replacement has been reported to stop the bleeding. In unﬁt patients, the options available are interventional or conservative management. We hereby report an elderly obese patient
with severe comorbidity with complicated HS involving a narrow aortic root. She underwent left ventricular outlet
myomectomy and aortic root replacement to promote better forward ﬂow and prevent restenosis and recurrence of
symptoms. She was discharged home symptom-free despite being on coumadin anticoagulants.
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Introduction

H

eyde's syndrome (HS) is a triad of aortic
stenosis (AS), acquired coagulopathy (Von
Willebrand syndrome -2A, (VWS-2A)) and
anaemia due to bleeding from intestinal angiodysplasia. Replacement of the aortic valve has
been reported to stop the bleeding. Recently,
transcatheter aortic valve implantation (TAVI) or
other conservative strategies have been recommended as treatments of choice for high-risk
surgical patients. In addition, TAVI may not be
technically suitable for a patient with a narrow
aortic root, and haemostatic abnormalities may
recur when a mismatch is found between the
patient and prosthesis size.

Case presentation
A 66-year-old woman was admitted with chest
discomfort and transient loss of consciousness. Her

von

willebrand,

Angiodysplasia,

Heyde's

syndrome,

past medical history included anaemia, hypertension, type 2 diabetes and morbid obesity with a BMI
of 42 and obstructive sleep apnoea. Blood investigations revealed a haemoglobin of 8.4 g/dl
(12e15 g/dl), a platelet count of 169/mm3 (150e410/
mm3) a troponin T of 16 ng/L (<14 ng/L) with normal
vitamin B12 and folate levels, but iron levels were
consistent with iron-deficiency anaemia with serum
iron 44 mg/dL (37e145 mg/dL), Iron saturation 11.8%
(15e45%) and serum ferritin 12.5 ng/mL (25e300 ng/
mL), transferrin and iron binding capacity 474.98 mg/
dL (250e435 mg/dL). Faecal occult blood was positive, and esophagogastroduodenoscopy was normal.
However, colonoscopy revealed multiple angiodysplasia in the splenic ﬂexure and rectum. She underwent clipping and argon plasma coagulation at
multiple sites (Fig. 1). AS was detected ﬁrst time
during this admission with transthoracic echocardiogram that showed severe AS, valve peak gradient
of 96 and mean 63 mm Hg, Aortic valve area 0.8 cm2,
left ventricular outlet diameter 1.9 cms and left
ventricular ejection fraction of 62% (Fig. 2). Her
subsequent investigations including molecular
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genetic analysis for Von Willebrand factor (VWF)
gene was negative. The Coomb's test was negative
and the Gliadin antibody tests was performed were
negative that excluded the diagnosis of haemolysis
and celiac disease respectively. The underlying malignancy or other structural diseases of gastrointestinal tract were also excluded.

She was clinically diagnosed with HS with a narrow aortic root complicated by obesity. She
continued to suffer from anaemia and required
multiple transfusions to improve her haemoglobin.
Considering her comorbidities with surgical EuroSCORE II of 16.8%, the initial choice of treatment
was decided to be TAVI rather than surgical AVR

Fig. 1. Endoscopic pictures showing angiodysplasia (yellow circle) in (a) and multiple argon coagulation treatment spots in (b).

(SAVR) during the multidisciplinary (MDT)
meeting. However, in view of her calciﬁed narrow
aortic outlet in relation to a large body surface area,
the decision was ﬁnally changed to Bentall procedure, as it will allow us to implant a larger biological
valve to avoid turbulence, provide better forward
ﬂow and avoid a possible mismatch that can occur
with surgical AVR. Patient underwent aortic outlet
myomectomy and Bentall procedure with Medtronic freestyle 25 size porcine valve under cardiopulmonary bypass (see Fig. 3). The postoperative
course was complicated by bleeding compounded
by atrial ﬁbrillation and hypoventilation, resulting
in a few unsuccessful weaning trials. Tracheostomy
was performed on the 11th postoperative day. She
needed several days of high dependency and rehabilitation care. Her tracheostomy was decannulated
on the 17th day and discharged home on the 23rd
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day with a haemoglobin of 10.6 g/dl. She did not
show any more signs of intestinal bleeding during
her hospital stay or follow-up for twenty months.
She was treated with coumadin for 3 months and
continued on aspirin.

Discussion
The evidence that AS is the root cause of coagulopathy in HS is compelling, with 5%e20% of these
patients manifesting recurrent bleeding [1] with
severity depending on the gradients across a stenotic AV [2]. VWS-2A arises from degradation of
VWF multimers by shear stress across the AV,
resulting in coagulopathy. These multimers are
required to maintain haemostasis in high-ﬂow
conditions, such as in intestinal arteriovenous malformations in patients with AS [3]. The pathogenesis
of angiodysplasia could be due to low-grade chronic

Fig. 2. Preoperative Transthoracic Echocardiography showing severe calciﬁed aortic valve in (a), a narrow LVOT gradient and AV area in (b) and
narrow Increased AV gradient in (c).
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Fig. 3. Postoperative transthoracic Echocardiography showing Decline in postop LVOT gradient in (a) and decline in AV gradient in (b).

hypoxia that stimulates sympathetic vasodilation
reﬂex progressing to ﬁxed smooth muscle relaxation
and true ectasia [4]. These could also be due to
mucosal hypoxia caused by cholesterol emboli or by
the altered pulse waveform secondary to AS. Most
of them remain undiagnosed and are found as an
incidental ﬁnding in 15%e25% of patients with
repeated bleeding [5]. Unfortunately, Von Willebrand factor test could not be performed in our
patient due to ﬁnancial constraints and the diagnosis was made on clinical grounds. VWS-2A also
occurs in other similar high-stress conditions such
as left ventricular assist device implantation, hypertrophic obstructive cardiomyopathy, ventricular
septal defect and patent ductus arteriosus.
Even though AV replacement eliminates the risk
of bleeding [1], the procedure itself may cause
serious bleeding complications. Other issues such as
type of procedure (open vs interventional), prosthesis (mechanical vs biological) and perioperative
anticoagulation are always debatable. More
recently, TAVI has emerged as a feasible option
with bioprosthetic valve [7] and postoperative lowdose aspirin. In the presence of prosthesis
mismatch, GI bleeding has been found to recur
because of the persistence of a pathophysiological
mechanism. We opted for Bentall procedure, as it
allowed us to place a larger valve with less gradient
and better haemodynamics. Unlike surgery, endoscopic cauterisation alone was only temporarily
successful and was associated with a high recurrence rate [6]. Our patient could even tolerate
warfarin anticoagulation without bleeding recurrence following corrective surgery for three months.
We opted 3 months of coumadin anticoagulation
followed by aspirin as per recent guidelins [9].
However, we fully agree that the associated
morbidity was not negligible, with signiﬁcant postoperative complications and increased length of
stay. Sleep-disordered breathing is highly prevalent
in obese patients [8] with associated upper airway
muscle weakness, vascular endothelial dysfunction,
cardiac arrhythmia, alveolar hypoventilation and
sensitivity to anaesthetic medications leading to
sudden cardiovascular death, myocardial infarction,
stroke, worsening overall postoperative recovery
and higher pacemaker use [10].
HS management requires a multidisciplinary
approach. Treatment options include octreotide
infusion, endoscopic interventions, colon surgery
and AV replacement. Surgical excision of angiodysplasia is a high risk in the presence of AS, and
studies have shown that bleeding recurrence remains with underlying AS pathophysiology [11]. If
AVR
cannot
stop
bleeding,
subsequent
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anaesthesia for bowel resection would be less
risky. In our patient, improvement in anaemia was
possibly due to the resolution of angiodysplasia
with improved cardiac output and recovery of
VWF multimers. This case report suggests that
more radical procedures offered to these high-risk
complicated HS patients, such as Bentall procedure, can still be associated with favourable outcomes. However, a careful understanding of
pathophysiology,
preoperative
optimisation
including a multidisciplinary approach, endoscopic treatment, blood transfusion, perioperative
echocardiography with appropriate postoperative
ventilatory and rehabilitation strategy will be key
to successful results.
To the best of our knowledge, this is the ﬁrst patient who successfully underwent Bentall procedure
in complicated HS with complete resolution of
anaemia despite coumadin anticoagulation. Larger
prospective studies are required to revise AVR
guidelines to include anaemia and GI bleeding as
criteria of the type, timing and type of surgery and
anticoagulation regimen.
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